Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07294118 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Study completion date: Aug 1, 2027 to Aug 2027
    • Start date changed from estimate of Dec 2025 to Jan 2, 2026
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Trial Details
NCT Number NCT07294118
Lead Sponsor The University of Texas Medical Branch, Galveston
Conditions
(from sponsor)		 Subarachnoid Hemorrhage, Aneurysmal, Headache, Opiate Dependence, Opioid Use
Related terms Headache, Opioid-Related Disorders, Subarachnoid Hemorrhage
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov